Clinical trial
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment…
NCT00160433 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00160433 |
|---|---|
| Title | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis. |
| Official title | A Phase II, 3-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Doses of J867 (0.5, 1.5 and 5 mg QD) Versus Placebo in Subjects With Endometriosis |
| Lead sponsor | Abbott, Industry |
| Collaborators | Jenapharm GmbH & Co. KG |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | Asoprisnil, Placebo |
| Enrollment | 131 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: